Who Can Legally Perform Morpheus8 in the UK

Ask who may legally perform Morpheus8 in the UK and most people assume the answer involves a register, a qualification and an inspector. It feels like the sort of thing that must be licensed. This is a device that drives insulated needle electrodes millimetres into the skin and discharges radiofrequency energy from the tip of each one, and the FDA has stated in writing that radiofrequency microneedling is a medical procedure, not a cosmetic treatment.

The honest answer is more uncomfortable than that, and it depends on which part of the UK you are standing in.

The short answer for England

There is currently no national licensing scheme in force for non-surgical cosmetic procedures in England.

The powers to create one exist. Section 180 of the Health and Care Act 2022 provides them, and the Government consulted on how to use them between 2 September and 28 October 2023, receiving over 11,800 responses. Further consultation and Parliamentary time are still required before any scheme can take effect.

Until then, nothing national says who may hold the handpiece. Rules do apply, and the rest of this article sets out which, but they govern the device, the premises and the provider rather than the individual. Where the law has not drawn a line, you have to draw it yourself, in the consultation room.

The rules that do apply to the machine

Medical devices placed on the Great Britain market must be registered with the MHRA, and a manufacturer based outside the UK must appoint a UK Responsible Person. That is a market access requirement, not a verdict on whether a device does what it is sold for, and the distinction matters, because registration is sometimes presented in clinic marketing as an endorsement. CE marks were accepted in Great Britain until 30 June 2023, with UKCA marking required after that, and those deadlines have since been amended by subsequent legislation. EU medical device rules continue to apply in Northern Ireland.

Two absences are worth stating plainly. A specific MHRA registration number, or UKCA or CE certificate details, for Morpheus8 could not be confirmed from a primary MHRA source. And no MHRA safety alert specific to radiofrequency microneedling was identified. The Central Alerting System is the authoritative place to check, and the MHRA has separately acted against certain mechanical microneedling pens, so an absent alert reflects what is on the record rather than a clean bill of health.

What the Government’s own proposal calls this device

The 2023 consultation response is unusually specific, and it names this exact category of device. It sorts procedures into three tiers.

The wording behind that third row reads: “the combination of 2 or more technologies to create a hybrid device, for example, the combination of radiofrequency and microneedling to treat lines, wrinkles, sagging skin, acne scars and stretch marks”. That is Morpheus8, in the Government’s own words. Microneedling alone is green. Radiofrequency alone is amber. Combine them and the proposal is explicit.

Amber matters for what it would require. A non-healthcare professional would need a licence and oversight by a named regulated healthcare professional, while a regulated healthcare professional could perform the procedure without oversight. Red is the tier that would become CQC regulated with registered premises, and this treatment is not proposed for red.

Under 18s would be prohibited unless approved by a doctor registered with the GMC, aligning with the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021. That point came close to consensus: 9,418 of 11,708 respondents, 80 percent, supported an age restriction across all procedures.

The Level 7 claim, and what the consultation actually said

Level 7 turns up constantly in clinic marketing, sometimes with the implication that it is legally required here. It is not.

The consultation response records that several respondents raised Level 7 qualifications for amber procedures. A Level 7 requirement was not mandated in the Government’s response. That is the whole of it.

Level 7 is still meaningful. The JCCP’s Competency Framework, published in 2018, defines it as advanced practice, and the JCCP’s paper on energy based devices recommends standardised clinical training and adverse event reporting, though it sets no operator qualification level for radiofrequency microneedling. Treat Level 7 as evidence about a person, not as proof that a rule has been met, because that rule has not been made.

Scotland is a different country, legally

In Scotland the picture is materially different, and heading somewhere stricter. Independent healthcare services must register with Healthcare Improvement Scotland, and providing an unregistered independent healthcare service is an offence under section 10Z9 of the National Health Service (Scotland) Act 1978. That is a criminal provision, not a code of practice.

The Scottish Government’s June 2025 consultation response proposes a three group model. Group 1, licensed by the local authority under the Civic Government (Scotland) Act 1982 unless the setting is already regulated by Healthcare Improvement Scotland, includes microneedling to a depth of 1.5 mm and radiofrequency treatments. Group 3, restricted to an appropriate healthcare professional, meaning a doctor, dentist, prescribing nurse or prescribing pharmacist, includes microneedling where the needles penetrate deeper than 1.5 mm, and any Group 1 or 2 procedure where an anaesthetic is used.

Now read that against how Morpheus8 is actually delivered. Needle depths run from 1 to 7 mm, and treatment is typically performed under topical or local anaesthetic. Either one alone places it in Group 3. Together they place it there twice over.

England’s proposal would let a supervised non-clinician treat you. Scotland’s would put the same treatment in the hands of a doctor, dentist or prescriber.

The Scottish Government’s page gives no commencement date, and none is available from primary sources, though trade press has reported a Non-Surgical Cosmetic Procedures Bill as the likely vehicle. This is the direction of travel, not the law as it stands.

Premises, and the licence almost nobody mentions

Morpheus8 delivered as an aesthetic procedure by a non-clinician is not in itself a CQC registrable regulated activity. Registration turns on whether the provider carries on a regulated activity as defined in the CQC’s scope of registration guidance, which clinics treating under the care of doctors or nurses should check directly. For a patient that means “we are CQC registered” and “we are not” can both be lawful, and neither says much about this treatment.

Local premises licensing is more useful. In Greater London, premises offering special treatments require a licence under Part II of the London Local Authorities Act 1991, and boroughs commonly list electrical treatments, including radiofrequency machines, alongside laser and IPL, as licensable. Outside London, councils may still require a massage and special treatment premises licence. It is the most checkable item here: a clinic either holds one or it does not.

Why the operator matters more here than elsewhere

All of this would be an administrative curiosity if the treatment were low consequence. It is not.

Morpheus8 is 510(k) cleared, not FDA approved. Clearance is a substantial equivalence pathway, showing a device is similar enough to one already on the market, and not a finding that it works. No Morpheus8 clearance names wrinkles, skin tightening, acne scars, cellulite, stretch marks or fat reduction: the cleared wording covers electrocoagulation, haemostasis, and coagulation or contraction of soft tissue. We go through it line by line in what the clearance actually says.

The FDA’s safety communication of 15 October 2025 reports burns, scarring, fat loss, disfigurement, nerve damage and the need for surgical repair, and two specialty societies responded by urging members to add those risks to consent forms. No sham controlled randomised trial of Morpheus8 exists, and the one independent systematic review that excluded industry funded studies rates the evidence base at Level of Evidence 5. That review names the largest single source of complication risk, and it is not the machine. It is user error, which is the subject of what can go wrong, and how often.

The manufacturer is no less direct. The operator manual states that the equipment is for use only by qualified medical professionals trained in the particular technique to be performed, and that radiofrequency energy can cause injury if used improperly. InMode’s own instructions set a higher bar than English law does. Some of the price gap between clinics tracks exactly that, as we cover in what actually drives the price.

What to ask before you book

None of this should make the decision frightening. It should make it answerable. A clinic that answers these calmly and specifically is telling you a great deal.

• Who will hold the handpiece on the day, are they a regulated healthcare professional, and if so, which register and what number?
• If not, who supervises them, is that person named, and are they on the premises during treatment?
• This treatment sits in amber under the proposed English scheme. Would you meet the amber requirements today, before you have to?
• What depth in millimetres, on which area, at what energy, and how is that adjusted for my skin type?
• In London, does the premises hold a special treatment licence? Is the device registered with the MHRA, and who is the UK Responsible Person?
• If something goes wrong, who manages it, is a prescriber available, and what does your consent form name?

That last one has a right answer. The societies responding to the FDA communication told their members to name burns, scarring, fat loss, disfigurement and nerve damage on consent forms. A form mentioning none of them is out of step with what the specialty itself now recommends.

If what is bothering you needs diagnosis rather than treatment, a lesion that has changed or a scar nobody has assessed, see a GP or a dermatologist first. Otherwise, book a consultation with us and put every one of those questions to us directly. We would far rather answer them than have you assume the law has already answered them on your behalf, because in England, today, it has not.